Explore 3 Stock Ideas & Industry Insights Download Free Report

News

PetMed Express (NASDAQ:PETS) Q4 EPS Misses by 0.45 USD

PetMed Express (NASDAQ:PETS) announced quarterlyearnings, reporting a loss of (0.41 USD) per share. This figure missed the consensus estimate of 0.04 USD by 0.45 USD. The company recorded a negative return onequityof 6.76% and a netmarginof -2.76%, reflecting challenges in profitability during the period.

Team Kalkine | 21 December 2025

OUTLOOK THERAPEUTICS (NASDAQ:OTLK) Beats Quarterly EPS Estimates by Narrow Margin

OUTLOOK THERAPEUTICS (NASDAQ:OTLK) released its quarterlyearningsresults on December 19, reporting a net loss that was slightly narrower than market expectations. The company posted an earnings per share (EPS) of (USD 0.22), compared with the consensus estimate of (USD 0.23), resulting in a beat of …

Team Kalkine | 21 December 2025

AngloGold Ashanti (NYSE: AU) Stock Rises Sharply as Gold Prices Climb

AngloGold Ashanti (NYSE:AU) share price performance in 2025 was closely linked to movements in the gold market. Gold prices rose more than 60% during the year, creating favourable conditions for gold mining equities globally. As a producer with operations across Africa, Australia, and the …

Team Kalkine | 21 December 2025

e.l.f. Beauty (NYSE: ELF) Extends Girls Wrestling Partnership for 2025 Event

e.l.f. Cosmetics, a brand under e.l.f. Beauty (NYSE:ELF), has extended itspartnershipwith The Wonder Women of Wrestling Foundation (WWOWF) for a second consecutive year. Under the renewed agreement, e.l.f. will continue as the beauty sponsor of the WWOWF Varsity Girls Wrestling Tournament scheduled for December …

Team Kalkine | 21 December 2025

Jefferies Revises Lowe’s (NYSE: LOW) Rating Outlook Following Earnings Update

Jefferies Financial Group has revised its price objective onLowe’s Companies, Inc. (NYSE: LOW), lifting the target toUSD 285 from USD 280, while maintaining its current stock rating. The update followed the company’s latest quarterly earnings release and reflects revised assumptions around near-term performance trends …

Team Kalkine | 21 December 2025

Fed Easing Expectations Lift Equities, Commodities Mixed, Dollar Steady

Market Movers:On Thursday, the top gainers were Aimei Health Technology Co., Ltd (+100.81%), followed by Athira Pharma, Inc. (+62.52%). On the contrary, Gain Therapeutics, Inc. (-44.44%), and Processa Pharmaceuticals, Inc (-41.62%) declined the most the same day.

Team Kalkine | 19 December 2025

BlackBerry (NYSE:BB) Posts Above-Guidance Revenue and Earnings in Q3FY26

BlackBerry Limited (NYSE:BB) released its third-quarter fiscal 2026 financial results after the market closed on December 18, providing revenue, earnings, and segment-level performance details for the three months ended November 30, 2025.

Team Kalkine | 19 December 2025

What Do Nike’s (NYSE:NKE) Q2FY26 Results Reveal About Recent Performance?

NIKE, Inc. (NYSE:NKE) released its financial results for the second quarter of fiscal year 2026 after U.S. market hours on December 18, 2025. The results cover the three-month period ended November 30, 2025, and provide insight into the company’s recent operating and financial performance.

Team Kalkine | 19 December 2025

Citigroup Adjusts Price Target and Rating for SolarEdge Technologies (NASDAQ:SEDG)

SolarEdge Technologies, Inc. (NASDAQ:SEDG) saw its price target lowered by Citigroup from$30.00 to $29.00in a research report issued on December 18, 2025, while maintaining its sell rating on the stock. This adjustment reflects Citigroup’s updated outlook based on its latest analysis of company performance …

Aditi Sarkar | 19 December 2025

HeartFlow (NASDAQ:HTFL) Stock Rises After Cardiology Groups Highlight Plaque Measurement

HeartFlow Inc. (NASDAQ:HTFL) shares advanced about 9% on Thursday following disclosures related to recent scientific statements issued by two major cardiovascular organizations. The movement came after the American College of Cardiology (ACC) and the American Heart Association (AHA) published statements emphasizing the clinical relevance …

Team Kalkine | 18 December 2025
Support

Hi! How can we help you today?

Loading…